Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
Released On
December 16, 2022
Expires On
December 16, 2023
Media Type
Internet
Completion Time
90 minutes
Specialty
Dermatology, Primary Care
Topic(s)
Dermatologic Disease, Women's Health
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Physicians’ Education Resource®, LLC, and HS Foundation.
This activity is supported by an educational grant from Novartis Pharmaceuticals.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
- Nurses — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is directed toward dermatologists, NPs, PAs, nurses, and other healthcare professionals who are involved in the treatment and management of HS. Primary care providers, women’s health professionals, and proctologists who may be involved in first-line diagnosis of HS will also be targeted.
Program Overview
This video-based program is designed for health care professionals to explore the diagnosis and treatment of patients with hidradenitis suppurativa (HS) through a unique perspective, putting the patient voice front and center. A patient will lend their expertise to this program by sharing their journey living with HS. This online activity focuses on the complex disease pathophysiology and etiology of HS, the clinical presentation and diagnostic evaluation, and the efficacy and safety of therapies recommended for both symptom control and agents that may modify the disease course of HS.
Learning Objectives
- Upon completion of this activity, participants should be better able to:
-
- Recognize the characteristic features of HS and the challenges that result from associated psychological and medical comorbidities.
- Determine when it is important to refer the patient to a dermatologist or other specialists for diagnosis further assessment, and/or care.
- Devise multifaceted and multidisciplinary treatment strategies for patients with HS which are informed by available evidence and individual patient needs.
- Develop individualized management plans for patients with HS which incorporate aspects of the patient journey.
Faculty
Tiffany T. Mayo, MD, FAAD
Associate Professor
Vice Chair of Diversity Equity and Inclusion
Director of Dermatology Clinical Research Unit
Department of Dermatology
The University of Alabama at Birmingham
Birmingham, AL
Gretchen M. Roth, MD
Assistant Professor
Department of Dermatology
Medical College of Wisconsin
Milwaukee, WI
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Tiffany T. Mayo, MD, FAAD
-
- Grant Research Support: Lilly, ChemoCentryx, Pfizer, Janssen, Galderma, BMS, Acelyrin
- Consultant: Janssen, Lilly, Leo Novartis, Pfizer, Bodewell, Arcutis, BMS
- Gretchen M. Roth, MD
-
- Consultant: AbbVie, Novartis; Other Support: study PI for clinical trial: Acelyrin
Nertaissa Cochran
Patient
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.